» Articles » PMID: 34992468

Prevalence and Predictors of Hypovitaminosis D in Ethiopian HIV-Infected Adults

Overview
Publisher Dove Medical Press
Date 2022 Jan 7
PMID 34992468
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypovitaminosis D is associated with bone fracture and cardiovascular disease in patients receiving antiretroviral therapy. Currently, there are few data on the magnitude of hypovitaminosis D in people living with HIV in Sub-Saharan country. Therefore, the present study determines the magnitude of hypovitaminosis D in people living with HIV and its associated factors in Ethiopia.

Methods: A cross-sectional study was conducted among 171 adult people living with HIV at Debre Berhan Specialized Hospital. Serum vitamin D was measured. Multivariate logistic regression analysis and p-value <0.05 was used to identify the associated factors of hypovitaminosis D.

Results: In the present study, the prevalence of hypovitaminosis D was 129/171 (75.4%), with 11/171 (6.4%) having vitamin D deficiency and 118/171 (69%) having vitamin D insufficiency. Female sex was significantly associated with hypovitaminosis D (AOR: 3.01, 95% CI = 1.381-6.561, P = 0.006).

Conclusion: Our study found a high burden of hypovitaminosis D among adult people living with HIV on antiretroviral therapy. Female sex was associated with hypovitaminosis D.

Citing Articles

Circulating 25-hydroxycholecalciferol and calcium levels, and alkaline phosphatase activity among people living with and without human immunodeficiency virus and injecting drugs in kenya.

Onyango A, Shaviya N, Budambula V, Orinda G, Anzala O, Aabid A BMC Infect Dis. 2024; 24(1):703.

PMID: 39020290 PMC: 11256408. DOI: 10.1186/s12879-024-09610-8.

References
1.
Portilla J, Moreno-Perez O, Serna-Candel C, Escoin C, Alfayate R, Reus S . Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV. J Int AIDS Soc. 2014; 17:18945. PMC: 4021989. DOI: 10.7448/IAS.17.1.18945. View

2.
Allavena C, Delpierre C, Cuzin L, Rey D, Viget N, Bernard J . High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother. 2012; 67(9):2222-30. DOI: 10.1093/jac/dks176. View

3.
Missailidis C, Hoijer J, Johansson M, Ekstrom L, Bratt G, Hejdeman B . Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden. Scand J Immunol. 2015; 82(1):55-62. PMC: 4691317. DOI: 10.1111/sji.12299. View

4.
Ezeamama A, Guwatudde D, Wang M, Bagenda D, Kyeyune R, Sudfeld C . Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study. Clin Nutr. 2015; 35(5):1110-7. PMC: 5289410. DOI: 10.1016/j.clnu.2015.08.007. View

5.
Vescini F, Cozzi-Lepri A, Borderi M, Re M, Maggiolo F, De Luca A . Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr. 2011; 58(2):163-72. DOI: 10.1097/QAI.0b013e31822e57e9. View